TOI Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: March 14, 2026
Report Source: 2025 Annual Report
Oncology Institute Inc. Stock Analysis TOI
The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 641 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The firm also provides management services to over 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Read More Oncology Institute Inc (TOI) Chart
Key Statistics of Oncology Institute Inc (TOI)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$3.93Volume
1.05MP/E Ratio (TTM)
-52 Week Range
Market Cap
393.38MAvg. Volume
1.45MDividend Yield
-Financial Metrics & Statements of Oncology Institute Inc (TOI)
FAQ's for Oncology Institute Inc (TOI)
- According to Musaffa’s Shariah screening methodology, Oncology Institute Inc (TOI) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.